Bridgefront Capital, LLC Elanco Animal Health Inc Transaction History

Bridgefront Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$8.79 - $14.58 $236,872 - $392,901	26,948 New	26,948 $253,000
Q3 2022 Nov 29, 2022	SELL	$12.41 - $32.42 $6,825 - $17,831	-550 Reduced 2.18%	24,641 $306,000
Q2 2022 Aug 12, 2022	BUY	$19.63 - $26.62 $494,499 - $670,584	25,191 New	25,191 $494,000
Q3 2021 Nov 12, 2021	SELL	$29.2 - $36.72 $253,514 - $318,803	-8,682 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$28.76 - $35.98 $249,694 - $312,378	8,682 New	8,682 $301,000

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.